Monographie - Dexrazoxane hydrochloride

Zadnji put ažurirano :
19/11/2024

Dexrazoxane hydrochloride

Kemijska struktura

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Cardioxane	Austrija, Brazil, Čile, Danska, Ekvador, Francuska, Irska, Italija, Madžarska, Meksiko, Njemačka, Peru, Poljska, Španjolska, Velika Britanija, Venecuela
Cyrdanax	Francuska, Njemačka
Dexrazoxane	Ekvador, S A D
Dexrazoxano	Meksiko, Peru
Razox	Peru
Razoxane	Kolumbija
Rhianta	Meksiko
Savene	Belgija, Danska, Finska, Francuska, Grčka, Irska, Italija, Madžarska, Nizozemska, Njemačka, Norveška, Poljska, Rumunjska, Španjolska, Švedska, Velika Britanija
Zinecard	Kanada, S A D
Zucordex	Meksiko

Bibliografija : Dexrazoxane hydrochloride

	Vrsta	Publikacija
381	Časopis	Beijnen JH, Van Gijn R. Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids. J Parenter Sci Technol 1993 ; 47: 166-171.
1423	Časopis	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1754	Časopis	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1949	Časopis	Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Clinical Cancer Research 2001 ; 7: 1569-1576.
1953	Časopis	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
2201	Časopis	Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. EJHP Science 2007 ; 13, 3: 55-59.
2224	Časopis	Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P. Dexrazoxane: Stabilià in soluzione. Bolletino SIFO 2007 ; 53: 178-180.
3581	Laboratorija	Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit Clinigen Healthcare 2013
3611	Časopis	Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. J Oncol Pharm Practice 2014 ; 20, 1: 58-64.

Mentions Légales